期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肝硬化低钠血症临床分析与意义

下载PDF
导出
摘要 肝硬化是临床各种慢性肝病发展的晚期阶段,肝硬化患者,尤其失代偿期由于体液稳态调节异常而极易并发低钠血症,严重低钠血症常促使或加重肝肾综合征与肝性脑病的发生,
作者 丛日荣
机构地区 辽宁凌源钢城中心医院
出处 《中国社区医师（医学专业）》 2013年第8期95-96,共2页
关键词 肝硬化 低钠血症 并发症
分类号 R575.2 [医药卫生—消化系统]
  • 相关文献

参考文献10

  • 1徐晓光,蔡洪培.肝硬化低钠血症研究进展[J].中华消化杂志,2002,22(9):560-562. 被引量：95
  • 2Elsenmenger WJ, Blondheim SH, Bongiovanni AM, Kunkel HG. Electrolyte studies on pa- tients with cirrhosis of the liver. J Clin Invest, 1950,29 : 1491 - 1499.
  • 3Gines P, Guevara M. Hyponatremia in cirrho- sis : pathogenesis, clinical significance, and management [ J ]. Hepatology, 2008,48 ( 3 ) : 1002 - 1010.
  • 4Heuman DM, Abou - Assi SG, Habib A, et al. Persistent ascites and serum sodium identify patients with cirrhosis and low MELDseores who are at high risk for early death[J].Hepa- tology,2004,40(4) :802 - 810.
  • 5Londono MC, Cardenas A, Guevara M, et al. MELD score and serum sodium in the predic- tion of survival of patients with cirrhosis awai- ting liver transplantation [ J ]. Gut, 2007, 56 (9) :1283 - 1290.
  • 6Gines P, Guevara M. Hyponatremia in cirrho- sis : pathogenesis, clinical significance, and management. Hepatology, 2008, 48:1002 - 1010.
  • 7Gines P, Jimenez W. Aquaretic agents : a new potential treatment of dilutional hyponatremia in cirrhosis . J Hepatol 1996,24:506 - 512.
  • 8向慧玲.肝硬化低钠血症与Vaptans[J].世界华人消化杂志,2010,18(12):1244-1249. 被引量：9
  • 9Londono MC, Cardenas A, Guevara M, Quinto L, de Las Heras D, Navasa M, Rimola A, Gar- cia - Valdecasas JC, Arroyo V, Gines P. MELD score and serum sodium in the predic-tion of transplantation. Gut 2007,56 : 1283 - 1290.
  • 10Borroni G, Maggi A, Sangiovanni A, Cazzaniga M, Saleno F. Clinical relevance of hy-ponatraemia for the hospital outcome of cir- rhotic patients. Dig Liver Dis, 2000,32 : 605 -610.

二级参考文献65

  • 1Elsenmenger WJ,Blondheim SH,Bongiovanni AM,Kunkel HG.Electrolyte studies on patients with cirrhosis of the liver.J Clin Invest 1950; 29:1491-1499.
  • 2Arroyo V,Rodés J,GutiáZrrez-Lizarraga MA,Revert L.Prognostic value of spontaneous hyponatremia in cirrhosis with ascites.Am J Dig Dis 1976; 21:249-256.
  • 3Ruf AE,Kremers WK,Chavez LL,Descalzi VI,Podesta LG,Villamil FG.Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.Liver Transpl 2005; 11:336-343.
  • 4Ginès P,Guevara M.Hyponatremia in cirrhosis:pathogenesis,clinical significance,and management.Hepatology 2008; 48:1002-1010.
  • 5Ackermann D.[Treatment of ascites,hyponatremia and hepatorenal syndrome in liver cirrhosis] Ther Umsch 2009; 66:747-751.
  • 6Londono MC,Guevara M,Rimola A,Navasa M,Taurà P,Mas A,Garcia-Valdecasas JC,Arroyo V,Ginès P.Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation.Gastroenterology 2006; 130:1135-1143.
  • 7Londono MC,Cárdenas A,Guevara M,QuintóL,de Las Heras D,Navasa M,Rimola A,GarciaValdecasas JC,Arroyo V,Gines P.MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.Gut 2007; 56:1283-1290.
  • 8Ginès P.Vaptans:a promising therapy in the management of advanced cirrhosis.J Hepatol 2007;46:1150-1152.
  • 9Decaux G,Soupart A,Vassart G.Non-peptide arginine-vasopressin antagonists:the vaptans.Lancet 2008; 371:1624-1632.
  • 10Olszewski W,Gluszek J.[Vasopressin antagonists in treatment of hyponatremia] Pol Arch Med Wewn 2007; 117:356-362.

共引文献102

中国社区医师（医学专业）
2013年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部